Enzymatica AB (ENZY) Stock Statistics & Valuation Metrics

Enzymatica AB has a market cap or net worth of kr450.27M. The enterprise value is kr583.59.

Enzymatica AB has 242,735,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Enzymatica AB’s return on equity (ROE) is -0.42 and return on invested capital (ROIC) is -41.66%.

The current PE Ratio of Enzymatica AB is ―. Enzymatica AB’s PEG ratio is 0.36.

In the last 12 months, Enzymatica AB had revenue of 53.90M and earned -51.89M in profits. Earnings per share was -0.21.

In the last 12 months, operating cash flow was -29.54M and capital expenditures 11.43M, giving a free cash flow of -18.11M billion.

Enzymatica AB pays an annual dividend of ―, resulting in a dividend yield of ―

Enzymatica AB upcoming earnings date is Oct 29, 2026, Before Open (Confirmed).

Enzymatica AB as a current ratio of 3.65, with Debt / Equity ratio of 14.42%

In the past 12 months, Enzymatica AB has paid -51.00K in taxes.

Enzymatica AB EV to EBITDA ratio is -9.17, with an EV/FCF ratio of -10.41.

Enzymatica AB has kr13.14M in cash and marketable securities with kr14.17M in debt, giving a net cash position of -kr1.02M billion.

Gross margin is 57.70%, with operating margin of -96.86%, and net profit margin of -96.27%.

The average price target for Enzymatica AB is ―, which is 11.43% higher than the current price. The consensus rating is ―